Status: current, Not sufficiently defined by necessary conditions definition status. Date: 05-Aug 2020. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 113320691000001111 | Papaveretum + Hyoscine hydrobromide (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 113320701000001111 | Papaveretum + Hyoscine hydrobromide | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Papaveretum + Hyoscine hydrobromide | Is a | Medicinal product acting as analgesic agent (product) | true | Inferred relationship | Existential restriction modifier | ||
| Papaveretum + Hyoscine hydrobromide | Is a | Medicinal product acting as antiemetic agent (product) | true | Inferred relationship | Existential restriction modifier | ||
| Papaveretum + Hyoscine hydrobromide | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules | Is a | True | Papaveretum + Hyoscine hydrobromide | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR